Treatment.com International Aktie Logo
CA8949421017

Treatment.com International Aktie

Ins Portfolio
Über 2000 Dividenden-Werte in einem kostengünstigen ETF. Jetzt entdecken
Anzeige

Kurse werden geladen...

Prognose

Für dieses Unternehmen liegen uns keine Analysten-Daten vor.

Scoring-Modelle

Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.

News

  • Foto von Treatment.com AI Closes Previously Announced Acquisition of Rocket Doctor Inc.

    Treatment.com AI Closes Previously Announced Acquisition of Rocket Doctor Inc.

    THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce, further to its news release of February 12, 2025, that it has closed the acquisition of 100% of the issued and outstanding securities of Rocket Doctor Inc. (the “Transaction”) pursuant to the terms and conditions of a Share Purchase Agreement dated February 11, 2025, as amended (the “Definitive Agreement”) with Rocket Doctor Inc. (“Rocket Doctor”) and the common shareholders of Rocket Doctor. Rocket Doctor is a Canadian federally incorporated company with a US Delaware subsidiary, which aims to transform the way healthcare is delivered, through empowering doctors to start their own virtual practices, thereby providing citizens with quick access to high-quality, comprehensive medical care, powered by advanced devices and proprietary technology.» Mehr auf globenewswire.com

  • Foto von Treatment.com AI and Aiyibotong collaborate to explore commercial opportunities for Clinical Decision Support in China and Far East

    Treatment.com AI and Aiyibotong collaborate to explore commercial opportunities for Clinical Decision Support in China and Far East

    Market for Clinical Decision Support (CDSS) in China is ~US$600 million by 2030 Aiyibotong has installed systems in >200 healthcare institutions in China Aiyibotong and Treatment.com AI both using proprietary artificial intelligence (AI) and Machine Learning (ML) platforms Co-marketing opportunities in China Combining Aiyibotong's CDSS with Treatment AI's Global Library of Medicine will look to create further differentiation and increased market share for Aiyibotong in the China and Far East markets VANCOUVER, British Columbia, April 01, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has recently signed a Collaborative Agreement on with Beijing Aiyi Botong Information Technology Ltd Limited (“Aiyibotong”). Each organization has a focus in providing enhanced clinical decision support for both healthcare professionals and patients, using innovative technologies including AI and machine learning.» Mehr auf globenewswire.com

  • Foto von REPEAT: Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access

    REPEAT: Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access

    Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care. Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) Announces Rocket Doctor's Growth and Expansion in Alberta, Empowering Independent Physicians and Enhancing Patient Access to Care.» Mehr auf globenewswire.com

Unternehmenszahlen

Im letzten Quartal hatte Treatment.com International Aktie einen Umsatz von 0,00 und ein Nettoeinkommen von 1,51 Mio
(EUR)Dez. 2024
YOY
Umsatz0,00100,00%
Bruttoeinkommen0,00100,00%
Nettoeinkommen1,51 Mio0,43%
EBITDA1,51 Mio158,94%

Fundamentaldaten

MetrikWert
Marktkapitalisierung
+12,72 Mio
Anzahl Aktien
58,00 Mio
52 Wochen-Hoch/Tief
+0,80 - +0,0413
DividendenNein
Beta
-0,62
KGV (PE Ratio)
2,31
KGWV (PEG Ratio)
0,07
KBV (PB Ratio)
+21,97
KUV (PS Ratio)
+2.111,06

Unternehmensprofil

Treatment.Com International Inc. bietet personalisierte Gesundheitsinformationsdienste in Kanada an. Es entwickelt auch eine mobile Anwendung für die Bewertung von Symptomen der Nutzer, um ihre gesundheitlichen Bedenken, Probleme und laufende Wellness-Management zu behandeln. Das Unternehmen bietet eine digitale Gesundheits-App, ein Bewertungsinstrument, das Einblicke in die Gesundheit bietet. Darüber hinaus bietet das Unternehmen medizinische Ausbildung, medizinische Klinik, und klinische Berater-Lösungen; und bietet Gesundheits-Informations-Ressource. Treatment.Com International Inc. wurde im Jahr 2018 gegründet und hat seinen Hauptsitz in Vancouver, Kanada.

Name
Treatment.com International Aktie
CEO
Dr. Essam Hamza M.D.
SitzVancouver, bc
Kanada
Website
Börsengang
Mitarbeiter3

Ticker Symbole

BörseSymbol
Pnk
TREIF
Cnq
TRUE.CN
Frankfurt
939.F
München
939.MU
Düsseldorf
939.DU
🍪

Parqet nutzt Cookies.Erfahre Mehr